GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Arqule, Inc. (ARQL) [hlAlert]

ArQule, Inc. is a biotechnology company engaged in the research and development of next-generation, small-molecule cancer therapeutics. The Company's targeted, broad-spectrum products and research programs are focused on key biological processes that are central to cancer. ArQule's lead clinical-stage products have been generated
from two scientific platforms: Cancer Survival Protein modulation and Activated Checkpoint Therapy. The Cancer Survival Protein modulation platform has generated a clinical-stage product that mediates its effects by inhibiting the activity of a molecule known as c-Met, which plays multiple roles in cancer cell growth, survival, invasion, angiogenesis and metastasis. The ACT platform is designed to kill cancer cells selectively while sparing normal cells through direct activation of DNA damage response/checkpoint pathways. The Company's lead ACT program, based on the E2F-1 pathway, is partnered with Roche.
( Total: 16 Current Stock Recommendations )
Arqule, Inc.   (16)
Hold 31% Buy 69%
Related companies
China Biologic ...   (4)
Buy 100%
ATHERSYS INC   (7)
Buy 100%
ACURA PHARMACEUTICAL   (2)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
Derma Sciences, Inc.   (2)
Buy 100%
Tenax Therapeutics ...   (2)
Buy 100%
ARCA BIOPHARMA INC.   (1)
Buy 100%
PROLOR Biotech, Inc.   (5)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Nutraceutical ...   (1)
Buy 100%
Show  

Date (ET)MemberRatingYTD
Gains
 
9/14/2007  
Buy
  
6/5/2008  
Hold
  
8/13/2008  
Buy
  
9/3/2008  
Buy
  
12/1/2008  
Buy
  
6/10/2009  
Buy
  
10/13/2009  
Buy
  
4/1/2010  
Buy
  
5/26/2011  
Buy
  
3/15/2012  
Buy
  
9/12/2012  
Buy
  
10/2/2012  
Hold
  
9/18/2013  
Hold
  
5/12/2014  
Hold
  
12/9/2015  
Hold
  
12/21/2015  
Buy
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy